HLNE Stock Analysis: Hamilton Lane | NASDAQ
Asset Management | NASDAQ, USA | Market Cap: 4.378m USD | 12M Return: -43.9% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 84.6M
EPS Trend: 95.4%
Qual. Beats: 4
Rev. Trend: 91.9%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 9.3 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Hamilton Lane Incorporated (NASDAQ: HLNE) is a Philadelphia-based private markets investment firm founded in 1991 that specializes in private equity and venture capital across the full company lifecycle, from early venture and emerging growth to buyouts, distressed, and mezzanine investments. The firm operates multiple alternative investment strategies, including direct credit, direct investments, fund of funds (primary and secondary), evergreen funds, and real assets, typically committing between $0.25 million and $100 million per company and favoring majority stakes in small- to mid-sized enterprises. Its investment focus spans a broad range of sectors such as technology, healthcare, energy, industrials, financials, and consumer services, with a preference for disruptive and innovative businesses, and it invests globally across North America, Europe, Asia/Pacific, Latin America, the Middle East, and Africa. Listed since its 2017 IPO and classified within the Financials sector (Asset Management & Custody Banks), Hamilton Lane supports institutional and private wealth clients with private markets exposure, supplementing its direct deal activity with comprehensive fund-of-funds and advisory capabilities.
- Evergreen and private wealth AUM growth drives fee earnings expansion
- Carried interest realizations depend on private market exit activity
- Fee compression and rate exposure pressure private markets margins
| Net Income: 249.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.18 > 0.02 and ΔFCF/TA 1.20 > 1.0 |
| NWC/Revenue: 28.34% < 20% (prev 27.96%; Δ 0.38% < -1%) |
| CFO/TA 0.19 > 3% & CFO 427.2m > Net Income 249.2m |
| Net Debt (70.6m) to EBITDA (487.8m): 0.14 < 3 |
| Current Ratio: 1.62 > 1.5 & < 3 |
| Outstanding Shares: last quarter (54.4m) vs 12m ago 32.70% < -2% |
| Gross Margin: 69.88% > 18% (prev 70.79%; Δ -0.92% > 0.5%) |
| Asset Turnover: 37.99% > 50% (prev 42.18%; Δ -4.18% > 0%) |
| Interest Coverage Ratio: 31.96 > 6 (EBIT TTM 477.9m / Interest Expense TTM 15.0m) |
| A: 0.09 (Total Current Assets 561.3m - Total Current Liabilities 346.2m) / Total Assets 2.30b |
| B: 0.27 (Retained Earnings 614.7m / Total Assets 2.30b) |
| C: 0.24 (EBIT TTM 477.9m / Avg Total Assets 2.00b) |
| D: 1.09 (Book Value of Equity 915.2m / Total Liabilities 838.4m) |
| Altman-Z'' = 4.24 = AA |
| DSRI: 0.83 (Receivables 175.7m/197.6m, Revenue 759.0m/713.0m) |
| GMI: 1.01 (GM 70.79% / 69.88%) |
| AQI: 1.10 (AQ_t 0.71 / AQ_t-1 0.65) |
| SGI: 1.06 (Revenue 759.0m / 713.0m) |
| TATA: -0.08 (NI 249.2m - CFO 427.2m) / TA 2.30b) |
| Beneish M = -3.05 (Cap -4..+1) = AA |
As of July 03, 2026, the stock is trading at USD 79.76 with a total of 1,044,433 shares traded. Over the past week, the price has changed by +4.64%, over one month by -5.31%, over three months by -14.69% and over the past year by -43.92%.
Current recommended Stop Loss: 73.30 (which is 8.1% or 1.4 ATR below the current price).
Hamilton Lane has received a consensus analysts rating of 2.83. Therefore, it is recommended to hold HLNE.
- StrongBuy: 0
- Buy: 0
- Hold: 5
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 135.6 | 70% |
P/E Trailing = 13.3159
P/E Forward = 12.0192
P/S = 5.7678
P/B = 3.7604
P/EG = 1.39
Revenue TTM = 759.0m USD
EBIT TTM = 477.9m USD
EBITDA TTM = 487.8m USD
Long Term Debt = 278.4m USD (from longTermDebt, last quarter)
Short Term Debt = unknown (none)
Debt = 434.5m USD (from shortLongTermDebtTotal, last quarter) + Leases 78.1m
Net Debt = 70.6m USD (calculated: Debt 434.5m - CCE 363.9m)
Enterprise Value = 4.45b USD (4.38b + Debt 434.5m - CCE 363.9m)
Interest Coverage Ratio = 31.96 (Ebit TTM 477.9m / Interest Expense TTM 15.0m)
EV/FCF = 10.56x (Enterprise Value 4.45b / FCF TTM 421.3m)
FCF Yield = 9.47% (FCF TTM 421.3m / Enterprise Value 4.45b)
FCF Margin = 55.51% (FCF TTM 421.3m / Revenue TTM 759.0m)
Net Margin = 32.83% (Net Income TTM 249.2m / Revenue TTM 759.0m)
Gross Margin = 69.88% ((Revenue TTM 759.0m - Cost of Revenue TTM 228.6m) / Revenue TTM)
Gross Margin QoQ = 69.78% (prev 69.34%)
Tobins Q-Ratio = 1.93 (Enterprise Value 4.45b / Total Assets 2.30b)
Interest Expense / Debt = 3.44% (Interest Expense 15.0m / Debt 434.5m)
Taxrate = 16.25% (75.2m / 462.9m)
NOPAT = 400.2m (EBIT 477.9m * (1 - 16.25%))
Current Ratio = 1.62 (Total Current Assets 561.3m / Total Current Liabilities 346.2m)
Debt / Equity = 0.47 (Debt 434.5m / totalStockholderEquity, last quarter 915.2m)
Debt / EBITDA = 0.14 (Net Debt 70.6m / EBITDA 487.8m)
Debt / FCF = 0.17 (Net Debt 70.6m / FCF TTM 421.3m)
Total Stockholder Equity = 844.3m (last 4 quarters mean from totalStockholderEquity)
RoA = 12.47% (Net Income 249.2m / Total Assets 2.30b)
RoE = 29.51% (Net Income TTM 249.2m / Total Stockholder Equity 844.3m)
RoCE = 42.56% (EBIT 477.9m / Capital Employed (Equity 844.3m + L.T.Debt 278.4m))
RoIC = 20.84% (NOPAT 400.2m / Invested Capital 1.92b)
WACC = 10.11% (E(4.38b)/V(4.81b) * Re(10.83%) + D(434.5m)/V(4.81b) * Rd(3.44%) * (1-Tc(0.16)))
Discount Rate = 10.83% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 43.19 | Cagr: 0.35%
[DCF] Terminal Value 72.49% ; FCFF base≈368.3m ; Y1≈422.2m ; Y5≈621.3m
[DCF] Fair Price = 161.6 (EV 7.13b - Net Debt 70.6m = Equity 7.06b / Shares 43.7m; r=10.11% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 95.41 | EPS CAGR: 24.70% | SUE: 0.85 | # QB: 4
Revenue Correlation: 91.87 | Revenue CAGR: 13.36% | SUE: -0.47 | # QB: 0
EPS current Quarter (2026-09-30): EPS=1.50 | Chg30d=-0.76% | Revisions=+25% | Analysts=6
EPS current Year (2027-03-31): EPS=6.10 | Chg30d=+1.59% | Revisions=+20% | GrowthEPS=+3.4% | GrowthRev=+16.8%
EPS next Year (2028-03-31): EPS=7.40 | Chg30d=-0.55% | Revisions=-25% | GrowthEPS=+21.3% | GrowthRev=+18.6%
[Analyst] Revisions Ratio: +25%